↓ Skip to main content

PLOS

Identification of Prostate-Specific G-Protein Coupled Receptor as a Tumor Antigen Recognized by CD8+ T Cells for Cancer Immunotherapy

Overview of attention for article published in PLOS ONE, September 2012
Altmetric Badge

Mentioned by

patent
6 patents

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
36 Mendeley
Title
Identification of Prostate-Specific G-Protein Coupled Receptor as a Tumor Antigen Recognized by CD8+ T Cells for Cancer Immunotherapy
Published in
PLOS ONE, September 2012
DOI 10.1371/journal.pone.0045756
Pubmed ID
Authors

Satoko Matsueda, Mingjun Wang, Jinsheng Weng, Ying Li, Bingnan Yin, Jia Zou, Qingtian Li, Wei Zhao, Weiyi Peng, Xavier Legras, Christopher Loo, Rong-Fu Wang, Helen Y. Wang

Abstract

Prostate cancer is the most common cancer among elderly men in the US, and immunotherapy has been shown to be a promising strategy to treat patients with metastatic castration-resistant prostate cancer. Efforts to identify novel prostate specific tumor antigens will facilitate the development of effective cancer vaccines against prostate cancer. Prostate-specific G-protein coupled receptor (PSGR) is a novel antigen that has been shown to be specifically over-expressed in human prostate cancer tissues. In this study, we describe the identification of PSGR-derived peptide epitopes recognized by CD8(+) T cells in an HLA-A2 dependent manner.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 25%
Student > Master 7 19%
Researcher 5 14%
Student > Bachelor 4 11%
Other 3 8%
Other 5 14%
Unknown 3 8%
Readers by discipline Count As %
Agricultural and Biological Sciences 8 22%
Biochemistry, Genetics and Molecular Biology 8 22%
Medicine and Dentistry 5 14%
Neuroscience 2 6%
Immunology and Microbiology 2 6%
Other 4 11%
Unknown 7 19%